{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T02:17:11Z","timestamp":1788401831432,"version":"build-2803163510"},"reference-count":41,"publisher":"BMJ","issue":"4","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Neurol Neurosurg Psychiatry"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1136\/jnnp-2014-310008","type":"journal-article","created":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T02:11:53Z","timestamp":1428631913000},"page":"373-378","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":92,"title":["Seropositivity for NT5c1A antibody in sporadic inclusion body myositis predicts more severe motor, bulbar and respiratory involvement"],"prefix":"10.1136","volume":"87","author":[{"given":"N A","family":"Goyal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T M","family":"Cash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U","family":"Alam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Enam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Tierney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Araujo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F H","family":"Mozaffar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Pestronk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Mozaffar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2015,4,9]]},"reference":[{"key":"key-10.1136\/jnnp-2014-310008-1","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1093\/brain\/awr217","article-title":"A 12-year follow-up in sporadic inclusion body myositis: an end stage with major disabilities","volume":"134","author":"Cox","year":"2011","journal-title":"Brain"},{"key":"key-10.1136\/jnnp-2014-310008-2","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.1093\/brain\/awr213","article-title":"Long-term observational study of sporadic inclusion body myositis","volume":"134","author":"Benveniste","year":"2011","journal-title":"Brain"},{"key":"key-10.1136\/jnnp-2014-310008-3","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1212\/01.wnl.0000192260.33106.bb","article-title":"Inclusion-body myositis: clinical, diagnostic, and pathologic aspects","volume":"66","author":"Engel","year":"2006","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2014-310008-4","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s11926-013-0329-z","article-title":"Update on treatment of inclusion body myositis","volume":"15","author":"Breithaupt","year":"2013","journal-title":"Curr Rheumatol Rep"},{"key":"key-10.1136\/jnnp-2014-310008-5","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1093\/brain\/112.3.727","article-title":"Inclusion body myositis. Observations in 40 patients","volume":"112","author":"Lotz","year":"1989","journal-title":"Brain"},{"key":"key-10.1136\/jnnp-2014-310008-6","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1097\/WCO.0b013e328357f211","article-title":"Pathogenesis and therapy of inclusion body myositis","volume":"25","author":"Greenberg","year":"2012","journal-title":"Curr Opin Neurol"},{"key":"key-10.1136\/jnnp-2014-310008-7","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/ana.21622","article-title":"Sporadic inclusion body myositis: pathogenic considerations","volume":"65","author":"Karpati","year":"2009","journal-title":"Ann Neurol"},{"key":"key-10.1136\/jnnp-2014-310008-8","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S1474-4422(07)70171-0","article-title":"Inclusion body myositis: current pathogenetic concepts and diagnostic and therapeutic approaches","volume":"6","author":"Needham","year":"2007","journal-title":"Lancet Neurol"},{"key":"key-10.1136\/jnnp-2014-310008-9","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S0889-857X(02)00030-3","article-title":"Muscle biopsy findings in inflammatory myopathies","volume":"28","author":"Dalakas","year":"2002","journal-title":"Rheum Dis Clin North Am"},{"key":"key-10.1136\/jnnp-2014-310008-10","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/ana.410390122","article-title":"Sporadic inclusion body myositis: counts of different types of abnormal fibers","volume":"39","author":"Pruitt","year":"1996","journal-title":"Ann Neurol"},{"key":"key-10.1136\/jnnp-2014-310008-11","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/0046-8177(89)90128-7","article-title":"Major histocompatibility complex class I antigen expression, immunolocalization of interferon subtypes, and T cell-mediated cytotoxicity in myopathies","volume":"20","author":"Emslie-Smith","year":"1989","journal-title":"Hum Pathol"},{"key":"key-10.1136\/jnnp-2014-310008-12","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/ana.410160206","article-title":"Monoclonal antibody analysis of mononuclear cells in myopathies. I: quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells","volume":"16","author":"Arahata","year":"1984","journal-title":"Ann Neurol"},{"key":"key-10.1136\/jnnp-2014-310008-13","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/ana.410230511","article-title":"Monoclonal antibody analysis of mononuclear cells in myopathies. V: identification and quantitation of T8+cytotoxic and T8+suppressor cells","volume":"23","author":"Arahata","year":"1988","journal-title":"Ann Neurol"},{"key":"key-10.1136\/jnnp-2014-310008-14","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/ana.410230111","article-title":"Expression of immunoreactive major histocompatibility complex products in human skeletal muscles","volume":"23","author":"Karpati","year":"1988","journal-title":"Ann Neurol"},{"key":"key-10.1136\/jnnp-2014-310008-15","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.it.2005.05.003","article-title":"Immunobiology of muscle: advances in understanding an immunological microenvironment","volume":"26","author":"Wiendl","year":"2005","journal-title":"Trends Immunol"},{"key":"key-10.1136\/jnnp-2014-310008-16","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/mus.21739","article-title":"Permissive environment for B-cell maturation in myositis muscle in the absence of B-cell follicles","volume":"42","author":"Salajegheh","year":"2010","journal-title":"Muscle Nerve"},{"key":"key-10.1136\/jnnp-2014-310008-17","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1093\/brain\/119.6.1887","article-title":"Inclusion body myositis in HIV-1 and HTLV-1 infected patients","volume":"119","author":"Cupler","year":"1996","journal-title":"Brain"},{"key":"key-10.1136\/jnnp-2014-310008-18","doi-asserted-by":"crossref","first-page":"e20266","DOI":"10.1371\/journal.pone.0020266","article-title":"Autoantibodies against a 43 KDa muscle protein in inclusion body myositis","volume":"6","author":"Salajegheh","year":"2011","journal-title":"PLoS ONE"},{"key":"key-10.1136\/jnnp-2014-310008-19","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/ana.23840","article-title":"Cytosolic 5\u2019-nucleotidase 1A autoimmunity in sporadic inclusion body myositis","volume":"73","author":"Larman","year":"2013","journal-title":"Ann Neurol"},{"key":"key-10.1136\/jnnp-2014-310008-20","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/ana.23822","article-title":"Autoantibodies to cytosolic 5\u2019-nucleotidase 1A in inclusion body myositis","volume":"73","author":"Pluk","year":"2013","journal-title":"Ann Neurol"},{"key":"key-10.1136\/jnnp-2014-310008-21","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/mus.24199","article-title":"Cytoplasmic 5\u2019-nucleotidase autoantibodies in inclusion body myositis: isotypes and diagnostic utility","volume":"50","author":"Greenberg","year":"2014","journal-title":"Muscle Nerve"},{"key":"key-10.1136\/jnnp-2014-310008-22","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.nmd.2013.08.007","article-title":"188th ENMC International Workshop: inclusion body myositis, 2\u20134 December 2011, Naarden, The Netherlands","volume":"23","author":"Rose","year":"2013","journal-title":"Neuromuscul Disord"},{"key":"key-10.1136\/jnnp-2014-310008-23","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1212\/WNL.44.6.1131","article-title":"Anti-MAG antibodies: major effects of antigen purity and antibody cross-reactivity on ELISA results and clinical correlation","volume":"44","author":"Pestronk","year":"1994","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2014-310008-24","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1212\/WNL.41.3.357","article-title":"Polyneuropathy syndromes associated with serum antibodies to sulfatide and myelin-associated glycoprotein","volume":"41","author":"Pestronk","year":"1991","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2014-310008-25","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/mus.20958","article-title":"Inclusion body myositis functional rating scale: a reliable and valid measure of disease severity","volume":"37","author":"Jackson","year":"2008","journal-title":"Muscle Nerve"},{"key":"key-10.1136\/jnnp-2014-310008-26","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1007\/s12603-011-0062-0","article-title":"Timed up and go test and risk of falls in older adults: a systematic review","volume":"15","author":"Beauchet","year":"2011","journal-title":"J Nutr Health Aging"},{"key":"key-10.1136\/jnnp-2014-310008-27","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1056\/NEJMoa0909859","article-title":"A randomized study of alglucosidase alfa in late-onset Pompe's disease","volume":"362","author":"van der Ploeg","year":"2010","journal-title":"N Engl J Med"},{"key":"key-10.1136\/jnnp-2014-310008-28","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1002\/mus.23843","article-title":"Long-term outcome in chronic inflammatory demyelinating polyneuropathy patients treated with intravenous immunoglobulin: a retrospective study","volume":"48","author":"Querol","year":"2013","journal-title":"Muscle Nerve"},{"key":"key-10.1136\/jnnp-2014-310008-29","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/mus.21880","article-title":"The Oculobulbar Facial Respiratory score is a tool to assess bulbar function in myasthenia gravis patients","volume":"43","author":"Farrugia","year":"2011","journal-title":"Muscle Nerve"},{"key":"key-10.1136\/jnnp-2014-310008-30","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1016\/j.rmed.2009.06.014","article-title":"\u201cReal-life\u201d effectiveness of omalizumab in patients with severe persistent allergic asthma: the PERSIST study","volume":"103","author":"Brusselle","year":"2009","journal-title":"Respir Med"},{"key":"key-10.1136\/jnnp-2014-310008-31","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1093\/rheumatology\/keq444","article-title":"28-Joint count disease activity score at 3months after diagnosis of early rheumatoid arthritis is strongly associated with direct and indirect costs over the following 4 years: the Swedish TIRA project","volume":"50","author":"Hallert","year":"2011","journal-title":"Rheumatology"},{"key":"key-10.1136\/jnnp-2014-310008-32","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1017\/S031716710002953X","article-title":"Inclusion body myositis associated with progressive dysphagia: treatment with cricopharyngeal myotomy","volume":"16","author":"Danon","year":"1989","journal-title":"Can J Neurol Sci"},{"key":"key-10.1136\/jnnp-2014-310008-33","first-page":"115","article-title":"Inclusion body myositis with cricopharyngeus muscle involvement and severe dysphagia","volume":"15","author":"Danon","year":"1992","journal-title":"Muscle Nerve"},{"key":"key-10.1136\/jnnp-2014-310008-34","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/0022-510X(92)90150-J","article-title":"Quantitative morphometric study of muscle in inclusion body myositis","volume":"112","author":"Verma","year":"1992","journal-title":"J Neurol Sci"},{"key":"key-10.1136\/jnnp-2014-310008-35","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1136\/jnnp.51.12.1542","article-title":"Dysphagia in inclusion body myositis","volume":"51","author":"Wintzen","year":"1988","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key-10.1136\/jnnp-2014-310008-36","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s10072-011-0814-y","article-title":"A dysphagia study in patients with sporadic inclusion body myositis (s-IBM)","volume":"33","author":"Murata","year":"2012","journal-title":"Neurol Sci"},{"key":"key-10.1136\/jnnp-2014-310008-37","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1136\/jnnp.72.5.650","article-title":"Human T cell leukaemia virus type I associated neuromuscular disease causing respiratory failure","volume":"72","author":"Littleton","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key-10.1136\/jnnp-2014-310008-38","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1378\/chest.104.3.975","article-title":"Inclusion body myositis as a cause of respiratory failure","volume":"104","author":"Cohen","year":"1993","journal-title":"Chest"},{"key":"key-10.1136\/jnnp-2014-310008-39","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1212\/01.WNL.0000145834.17020.86","article-title":"Primary respiratory failure in inclusion body myositis","volume":"63","author":"Voermans","year":"2004","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2014-310008-40","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1093\/brain\/124.10.2000","article-title":"Respiratory muscle strength and ventilatory failure in amyotrophic lateral sclerosis","volume":"124","author":"Lyall","year":"2001","journal-title":"Brain"},{"key":"key-10.1136\/jnnp-2014-310008-41","doi-asserted-by":"crossref","first-page":"547","DOI":"10.4049\/jimmunol.178.1.547","article-title":"A local antigen-driven humoral response is present in the inflammatory myopathies","volume":"178","author":"Bradshaw","year":"2007","journal-title":"J Immunol"}],"container-title":["Journal of Neurology, Neurosurgery & Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jnnp-2014-310008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T18:00:19Z","timestamp":1601056819000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnnp.bmj.com\/lookup\/doi\/10.1136\/jnnp-2014-310008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,9]]},"references-count":41,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2016,3,15]]},"published-print":{"date-parts":[[2016,4]]}},"alternative-id":["10.1136\/jnnp-2014-310008"],"URL":"https:\/\/doi.org\/10.1136\/jnnp-2014-310008","relation":{},"ISSN":["0022-3050","1468-330X"],"issn-type":[{"value":"0022-3050","type":"print"},{"value":"1468-330X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,9]]}}}